Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona's products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.
Suite 60W
221 West Philadelphia Street
York, Pennsylvania 28277-3607
Phone: 18445463722
www.dentsplysirona.com
No summary available.
No summary available.
DENTSPLY SIRONA Inc. (NASDAQ: XRAY ) shares are trading higher on Wednesday. The company reported second-quarter adjusted earnings per share of 49 cents, missing the street view of 50 cents, and quarterly sales of $984 million, missing the analyst consensus of $995.66 million . According to William Blair analyst Brandon Vazquez, largest miss came from Connected Technology Solutions (equipment), which was down 16% on an organic basis. “Our second quarter results were unfavorably impacted by lower demand in our Connected Technology Solutions segment due to continued macroeconomic and competitive pressure,” said Simon Campion, President and Chief Executive Officer. Also Read: Asia Markets Up, Europe Opens Higher, Crude Advances 2.6% – Global Markets Today While US Slept In the second quarter of 2024, the company repurchased $150 million in stock and plans to buy back an additional $100 million in the third quarter. In his research note, Vazuez adds that end-markets remain challenging, and Dentsply is not immune to headwinds, but the company has levers to pull to help outperform peers (costsavings, unique products, and share …
Patterson Companies (PDCO) stock trades lower as Dentsply Sirona (XRAY) decides against renewing distribution agreements. Read more here.
Dentsply Sirona (NASDAQ: XRAY ) just reported results for the second quarter of 2024. Dentsply Sirona reported earnings per share of 49 cents. This was below the analyst estimate for EPS of 50 cents. The company reported revenue of $984.00 million. This was 1.19% worse than the analyst estimate for revenue of $995.89 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace .
YORK (PENNSYLVANIA) (dpa-AFX) - Below are the earnings highlights for Dentsply Sirona Inc (XRAY):Earnings: -$4 million in Q2 vs. $86 million in the same period last year. EPS: -$0.02 in Q2 vs. $0….
CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2024.
No summary available.
